Resultats de la cerca - Per Odin

Refinar resultats
  1. 1
    Algorithms for the treatment of motor problems in Parkinson's disease

    Algorithms for the treatment of motor problems in Parkinson's disease per Espen Dietrichs, Per Odin

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up

    Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up per K. Pietz, Peter Hagell, Per Odin

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease

    Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease per Kristina Rosqvist, Anette Schrag, Per Odin

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Immunohistochemical localization of cellCAM 105 in rat tissues: appearance in epithelia, platelets, and granulocytes.

    Immunohistochemical localization of cellCAM 105 in rat tissues: appearance in epithelia, platelets, and granulocytes. per Per Odin, Maria Asplund, Chia‐Jung Busch, Björn Öbrink

    Publicat 1988
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease

    Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease per Manzur Kader, Susanne Iwarsson, Per Odin, Maria H Nilsson

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease

    Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease per Daniel J. van Wamelen, Sotirios Grigoriou, К. Ray Chaudhuri, Per Odin

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Factors associated with life satisfaction in Parkinson's disease

    Factors associated with life satisfaction in Parkinson's disease per Kristina Rosqvist, Peter Hagell, Per Odin, Henrik Ekström, Susanne Iwarsson, Maria H Nilsson

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson’s disease

    Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson’s disease per Matthias Löhle, Alexander Bremer, Florin Gandor, Jonathan Timpka, Per Odin, Georg Ebersbach, Alexander Storch

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

    Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients per Dag Nyholm, Per Odin, Anders Johansson, Krai Chatamra, Charles Locke, Sandeep Dutta, Ahmed A. Othman

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease

    Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease per Lars Lau Rakêt, Daniel Oudin Åström, Jenny M. Norlin, Klas Kellerborg, Pablo Martínez‐Martín, Per Odin

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Transdermal rotigotine for the perioperative management of Parkinson’s disease

    Transdermal rotigotine for the perioperative management of Parkinson’s disease per Ullrich Wüllner, Jan Kassubek, Per Odin, Michael Schwarz, Markus Naumann, Hermann-Josef Häck, Babak Boroojerdi, Heinz Reichmann

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future

    Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future per К. Ray Chaudhuri, Mubasher A. Qamar, Thadshani Rajah, Philipp Alexander Loehrer, Anna Sauerbier, Per Odin, Peter Jenner

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach

    Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel appr... per Angelo Antonini, A. Jon Stoessl, Leah Kleinman, Anne Skalicky, Thomas S. Marshall, Kavita Sail, Koray Onuk, Per Odin

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The <scp>COVID</scp>‐19 Experience

    Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The <scp>COVID</scp>‐19 Experience per Alfonso Fasano, Angelo Antonini, Regina Katzenschlager, Paul Krack, Per Odin, Andrew Evans, Thomas Foltynie, Jens Volkmann, Marcelo Merello

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use

    The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use per Daniel J. van Wamelen, Pablo Martínez‐Martín, Daniel Weintraub, Anette Schrag, Angelo Antonini, Cristian Falup‐Pecurariu, Per Odin, К. Ray Chaudhuri

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery

    Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery per Thomas Müller, Teus van Laar, David R. Cornblath, Per Odin, Fabian Klostermann, Francisco Grandas, Georg Ebersbach, Péter Urbán, Francesc Valldeoriola, Angelo Antonini

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.

    Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study. per Lauge Østergaard, Lene Werdelin, Per Odin, Olle Lindvall, E. Dupont, Peter Brøgger Christensen, E Boisen, Niels Bjørn Jensen, SH Ingwersen, Michelle Schmiegelow

    Publicat 1995
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease per Per Odin, К. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review

    The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review per Angelo Antonini, Per Odin, Rajesh Pahwa, Jason Aldred, Ali Alobaidi, Yash J. Jalundhwala, Pavnit Kukreja, Lars Bergmann, Sushmitha Inguva, Yanjun Bao, К. Ray Chaudhuri

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?

    Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future? per Daniel J. van Wamelen, Jirada Sringean, Dhaval Trivedi, Camille Carroll, Anette Schrag, Per Odin, Angelo Antonini, Bastiaan R. Bloem, Roongroj Bhidayasiri, К. Ray Chaudhuri

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: